![ACS Journal Cancer – Top advances of the year: Perioperative therapy for lung cancer](https://oncodaily.com/pub/uploads/2024/05/acs.png)
Photo taken from
ACS Journal Cancer/X
May 13, 2024, 06:09
ACS Journal Cancer – Top advances of the year: Perioperative therapy for lung cancer
ACS Journal Cancer shared a post on X:
“Top advances of the year: Perioperative therapy for lung cancer.
2023 saw multiple positive trials of ICIs incorporated into novel treatment paradigms for early stage NSCLC, including overall survival improvement.”
Read further.
Source: ACS Journal Cancer/X